US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist
  • 17.590
  • +0.020+0.11%
Close Feb 14 16:00 ET
  • 17.590
  • 0.0000.00%
Post 17:01 ET
1.33BMarket Cap-6.11P/E (TTM)

Nurix Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Nov 30, 2024
(Q4)Nov 30, 2024
(Q3)Aug 31, 2024
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-112.11%-172.58M
-282.66%-48.75M
-2.54%-42.18M
-114.98%-39.71M
13.42%-41.95M
49.09%-81.37M
170.32%26.69M
11.18%-41.13M
43.89%-18.47M
-13.66%-48.45M
Net income from continuing operations
-34.47%-193.57M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
Operating gains losses
-94.42%31K
----
----
----
----
6,077.78%556K
--12K
--448K
--40K
--56K
Depreciation and amortization
20.32%16.43M
14.53%4.3M
22.52%4.15M
22.74%4.09M
22.26%3.89M
26.33%13.65M
23.71%3.76M
17.26%3.38M
26.63%3.33M
41.15%3.18M
Other non cash items
--286K
--0
----
----
----
----
----
----
----
----
Change In working capital
-191.45%-18.4M
-99.24%449K
81.73%-2.7M
-12.04%-5.94M
45.14%-10.21M
205.78%20.12M
3,160.35%58.82M
-40.04%-14.78M
-319.02%-5.3M
-107.72%-18.62M
-Change in receivables
--0
--0
----
----
----
--0
--2M
----
----
----
-Change in prepaid assets
-121.46%-459K
-194.00%-1.23M
-127.93%-570K
-92.11%169K
171.79%1.17M
295.52%2.14M
-136.07%-417K
377.69%2.04M
214,300.00%2.14M
-7.46%-1.63M
-Change in payables and accrued expense
259.40%17.03M
115.00%16.61M
103.92%7.13M
-49,468.42%-9.38M
140.94%2.66M
-37.42%4.74M
222.28%7.73M
481.06%3.5M
-99.76%19K
-90.15%-6.51M
-Change in other current liabilities
-2.39%-6.42M
-24.25%-1.65M
9.70%-1.68M
8.31%-1.63M
-11.98%-1.46M
-28.68%-6.27M
-11.41%-1.33M
-64.10%-1.86M
16.73%-1.78M
-219.12%-1.3M
-Change in other working capital
-246.31%-28.55M
-126.13%-13.28M
53.92%-7.59M
186.47%4.91M
-37.04%-12.59M
173.28%19.51M
1,287.02%50.84M
-77.21%-16.47M
39.81%-5.68M
-153.70%-9.18M
Cash from discontinued investing activities
Operating cash flow
-112.11%-172.58M
-282.66%-48.75M
-2.54%-42.18M
-114.98%-39.71M
13.42%-41.95M
49.09%-81.37M
170.32%26.69M
11.18%-41.13M
43.89%-18.47M
-13.66%-48.45M
Investing cash flow
Cash flow from continuing investing activities
-477.32%-257.71M
-879.73%-140.82M
-193.69%-21.34M
-399.03%-131.07M
121.02%35.51M
151.13%68.3M
-126.13%-14.37M
136.11%22.78M
1,019.85%43.83M
-59.86%16.07M
Net PPE purchase and sale
-10.38%-9.27M
18.57%-2.11M
4.55%-2.35M
-79.35%-1.94M
-26.66%-2.88M
31.39%-8.4M
-0.78%-2.59M
28.06%-2.46M
61.28%-1.08M
34.42%-2.28M
Net investment purchase and sale
-423.90%-248.44M
-1,076.72%-138.71M
-175.26%-18.99M
-387.53%-129.13M
109.30%38.4M
94.47%76.7M
-120.47%-11.79M
142.30%25.23M
2,372.82%44.91M
-57.83%18.35M
Cash from discontinued investing activities
Investing cash flow
-477.32%-257.71M
-879.73%-140.82M
-193.69%-21.34M
-399.03%-131.07M
121.02%35.51M
151.13%68.3M
-126.13%-14.37M
136.11%22.78M
1,019.85%43.83M
-59.86%16.07M
Financing cash flow
Cash flow from continuing financing activities
14,996.89%485.67M
2,864,485.71%200.52M
2,586.03%45.77M
950,908.00%237.75M
9.66%1.62M
-97.25%3.22M
105.19%7K
-98.52%1.7M
-94.21%25K
-0.47%1.48M
Net common stock issuance
--478.5M
--199.07M
--41.87M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
122.94%7.17M
20,600.00%1.45M
128.76%3.9M
704.00%201K
9.66%1.62M
6.07%3.22M
100.01%7K
-98.23%1.7M
-94.21%25K
-0.47%1.48M
Cash from discontinued financing activities
Financing cash flow
14,996.89%485.67M
2,864,485.71%200.52M
2,586.03%45.77M
950,908.00%237.75M
9.66%1.62M
-97.25%3.22M
105.19%7K
-98.52%1.7M
-94.21%25K
-0.47%1.48M
Net cash flow
Beginning cash position
-15.06%55.53M
131.33%99.95M
96.61%117.69M
47.12%50.71M
-15.06%55.53M
-19.08%65.38M
-10.84%43.21M
41.06%59.86M
-56.74%34.47M
-19.08%65.38M
Current changes in cash
662.30%55.37M
-11.12%10.95M
-6.56%-17.75M
163.82%66.98M
84.42%-4.81M
36.13%-9.85M
-27.16%12.32M
-376.51%-16.65M
168.16%25.39M
-2,681.55%-30.9M
End cash Position
99.72%110.9M
99.72%110.9M
131.33%99.95M
96.61%117.69M
47.12%50.71M
-15.06%55.53M
-15.06%55.53M
-10.84%43.21M
41.06%59.86M
-56.74%34.47M
Free cash flow
-102.59%-181.86M
-310.99%-50.86M
-2.14%-44.52M
-113.01%-41.64M
11.62%-44.84M
47.83%-89.77M
159.49%24.1M
12.34%-43.59M
45.25%-19.55M
-10.04%-50.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Nov 30, 2024(Q4)Nov 30, 2024(Q3)Aug 31, 2024(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -112.11%-172.58M-282.66%-48.75M-2.54%-42.18M-114.98%-39.71M13.42%-41.95M49.09%-81.37M170.32%26.69M11.18%-41.13M43.89%-18.47M-13.66%-48.45M
Net income from continuing operations -34.47%-193.57M-39.55%-58.55M-32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M
Operating gains losses -94.42%31K----------------6,077.78%556K--12K--448K--40K--56K
Depreciation and amortization 20.32%16.43M14.53%4.3M22.52%4.15M22.74%4.09M22.26%3.89M26.33%13.65M23.71%3.76M17.26%3.38M26.63%3.33M41.15%3.18M
Other non cash items --286K--0--------------------------------
Change In working capital -191.45%-18.4M-99.24%449K81.73%-2.7M-12.04%-5.94M45.14%-10.21M205.78%20.12M3,160.35%58.82M-40.04%-14.78M-319.02%-5.3M-107.72%-18.62M
-Change in receivables --0--0--------------0--2M------------
-Change in prepaid assets -121.46%-459K-194.00%-1.23M-127.93%-570K-92.11%169K171.79%1.17M295.52%2.14M-136.07%-417K377.69%2.04M214,300.00%2.14M-7.46%-1.63M
-Change in payables and accrued expense 259.40%17.03M115.00%16.61M103.92%7.13M-49,468.42%-9.38M140.94%2.66M-37.42%4.74M222.28%7.73M481.06%3.5M-99.76%19K-90.15%-6.51M
-Change in other current liabilities -2.39%-6.42M-24.25%-1.65M9.70%-1.68M8.31%-1.63M-11.98%-1.46M-28.68%-6.27M-11.41%-1.33M-64.10%-1.86M16.73%-1.78M-219.12%-1.3M
-Change in other working capital -246.31%-28.55M-126.13%-13.28M53.92%-7.59M186.47%4.91M-37.04%-12.59M173.28%19.51M1,287.02%50.84M-77.21%-16.47M39.81%-5.68M-153.70%-9.18M
Cash from discontinued investing activities
Operating cash flow -112.11%-172.58M-282.66%-48.75M-2.54%-42.18M-114.98%-39.71M13.42%-41.95M49.09%-81.37M170.32%26.69M11.18%-41.13M43.89%-18.47M-13.66%-48.45M
Investing cash flow
Cash flow from continuing investing activities -477.32%-257.71M-879.73%-140.82M-193.69%-21.34M-399.03%-131.07M121.02%35.51M151.13%68.3M-126.13%-14.37M136.11%22.78M1,019.85%43.83M-59.86%16.07M
Net PPE purchase and sale -10.38%-9.27M18.57%-2.11M4.55%-2.35M-79.35%-1.94M-26.66%-2.88M31.39%-8.4M-0.78%-2.59M28.06%-2.46M61.28%-1.08M34.42%-2.28M
Net investment purchase and sale -423.90%-248.44M-1,076.72%-138.71M-175.26%-18.99M-387.53%-129.13M109.30%38.4M94.47%76.7M-120.47%-11.79M142.30%25.23M2,372.82%44.91M-57.83%18.35M
Cash from discontinued investing activities
Investing cash flow -477.32%-257.71M-879.73%-140.82M-193.69%-21.34M-399.03%-131.07M121.02%35.51M151.13%68.3M-126.13%-14.37M136.11%22.78M1,019.85%43.83M-59.86%16.07M
Financing cash flow
Cash flow from continuing financing activities 14,996.89%485.67M2,864,485.71%200.52M2,586.03%45.77M950,908.00%237.75M9.66%1.62M-97.25%3.22M105.19%7K-98.52%1.7M-94.21%25K-0.47%1.48M
Net common stock issuance --478.5M--199.07M--41.87M----------0--0--0--------
Proceeds from stock option exercised by employees 122.94%7.17M20,600.00%1.45M128.76%3.9M704.00%201K9.66%1.62M6.07%3.22M100.01%7K-98.23%1.7M-94.21%25K-0.47%1.48M
Cash from discontinued financing activities
Financing cash flow 14,996.89%485.67M2,864,485.71%200.52M2,586.03%45.77M950,908.00%237.75M9.66%1.62M-97.25%3.22M105.19%7K-98.52%1.7M-94.21%25K-0.47%1.48M
Net cash flow
Beginning cash position -15.06%55.53M131.33%99.95M96.61%117.69M47.12%50.71M-15.06%55.53M-19.08%65.38M-10.84%43.21M41.06%59.86M-56.74%34.47M-19.08%65.38M
Current changes in cash 662.30%55.37M-11.12%10.95M-6.56%-17.75M163.82%66.98M84.42%-4.81M36.13%-9.85M-27.16%12.32M-376.51%-16.65M168.16%25.39M-2,681.55%-30.9M
End cash Position 99.72%110.9M99.72%110.9M131.33%99.95M96.61%117.69M47.12%50.71M-15.06%55.53M-15.06%55.53M-10.84%43.21M41.06%59.86M-56.74%34.47M
Free cash flow -102.59%-181.86M-310.99%-50.86M-2.14%-44.52M-113.01%-41.64M11.62%-44.84M47.83%-89.77M159.49%24.1M12.34%-43.59M45.25%-19.55M-10.04%-50.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.